Title: Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/
CD166+ by inhibiting programmed death-ligand 1
Version: 4 Date: 04 Oct 2024
Reviewer:  Anwar Ashraf Abouelnasr
Reviewer's report:
After reviewing the responses, it is deemed that they are satisfactory, and the manuscript is
suitable for publication in its current form.
Title: Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/
CD166+ by inhibiting programmed death-ligand 1
Version: 4 Date: 04 Oct 2024
Reviewer:  Anwar Ashraf Abouelnasr
Reviewer's report:
After reviewing the responses, it is deemed that they are satisfactory, and the manuscript is
suitable for publication in its current form.
Please review this paper.
user
Title: Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/
CD166+ by inhibiting programmed death-ligand 1
Version: 4 Date: 04 Oct 2024
Reviewer:  Anwar Ashraf Abouelnasr
Reviewer's report:
After reviewing the responses, it is deemed that they are satisfactory, and the manuscript is
suitable for publication in its current form.
assistant